Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome (Q34269186)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome |
scientific article |
Statements
1 reference
Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome (English)
1 reference
Hagop Kantarjian
1 reference
William G Wierda
1 reference
Susan O'Brien
1 reference
Michael J Keating
1 reference
William Plunkett
1 reference
Apostolia M Tsimberidou
1 reference
Xavier Badoux
1 reference
Chronic Lymphocytic Leukemia Research Consortium
1 reference
Sijin Wen
1 reference
Jeffrey A Jones
1 reference
Thomas J Kipps
1 reference
27 June 2013
1 reference
1 reference
13
1 reference
5
1 reference
568-574
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference